-
-
-
-
-
-
-
Fresenius Medical Care starts 2025 with strong organic revenue and income growth
-
-
-
-
-
-
-
Fresenius Medical Care enters into favorable settlement agreement with U. S. government with positive earnings impact of approx. EUR 175 million - 2023 earnings outlook raised
-
-
-
-
-
-
-
CytoSorbents Achieves Fourth Consecutive Quarter of Record CytoSorb® Sales
-
-
-
-
-
-
-
NxStage Reports Record Second Quarter Financial Results And Improves Financial Guidance For 2015
-
-
-
-
-
-
1,197,524 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

